RA Capital Healthcare Fund, Director: Mineralys Therapeutics MLYS Buy · Filed 25/03/17

Trade details

Type: Insider buy
Amount: $17,499,996
Shares · price: 1,296,296 sh · $13.50 a share
Held after: 4,280,051 sh
Stock: Mineralys Therapeutics MLYS
Person: RA Capital Healthcare FundDirector
Trade date: 25/03/13
Filed: 25/03/17
Days to filing: 4 days

First buy in 2 years

Since the last buy: 2.1 years
Last buy: 23/02/14
Insiders buying this week: 10 insiders
Holding change: +43.4%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/11~25/04/12

RA Capital Healthcare Fund's recent trades

RA Capital Healthcare FundDirector, 10% Stockholder
Planned saleSionna Therapeutics
Planned sale
Sionna Therapeutics
SION
$21.8M
3,448,811 sh
$21.8M
Filed 09/17
Traded 09/17
RA Capital Healthcare FundDirector
Planned saleSepterna
Planned sale
Septerna
SEPN
$36M
746,500 sh
$36M
Filed 08/12
Traded 08/12
RA Capital Healthcare FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
RA Capital Healthcare FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
RA Capital Healthcare Fund10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17